Lyme in the News

[blimeyitslymie]

The New York Times
New York NY
October 8, 2006

MAGAZINE

DIAGNOSIS

Pregnant With Possibilities

By LISA SANDERS, M.D.

Published: October 8, 2006

1. Symptoms

[Photos omitted on LymeInfo – go to URL at top of page to view photo
captioned below.]


Illustration by Jan Schwochow

Fever Drenching sweats alternated with chills at night. Body aches
Not just in the neck, but hotness and soreness all over. Liver
abnormalities Revealed by blood tests.

It was the woman's husband who noticed the first symptom. The couple
were walking along a street of town houses on the Upper West Side of
Manhattan. Her husband had pointed to some architectural detail and
looked to see her reaction. The young woman tipped her whole body
back in order to look up. "What's wrong with your neck?" her husband
asked. "Are you O.K.?" As soon as he asked, she realized that her
neck felt stiff and that she wasn't O.K. She was well into her fifth
month of pregnancy and was used to the minor aches and pains of her
new shape, but this, this was different. She felt hot, achy, sore —
not just in her neck but all over. They walked to a pharmacy and
bought a thermometer. Her temperature was 101.

They had looked forward to this Friday-evening visit to the city,
but now the woman felt too ill to enjoy it. They decided to go back
home to Connecticut. She phoned her OB-GYN's office and spoke with
the doctor on call. After listening to her symptoms, he said he
wasn't worried. It was probably a virus. He recommended Tylenol and
rest. That night, the woman alternated between teeth-rattling chills
and a fever that left her drenched in sweat.

The next morning she still had the fever and aches. She thought it
over. She was a physician, an internist — she should be able to
figure this out. Lying in bed, she tried to think about herself the
way she might any other patient. She was 30 and she was healthy. She
didn't smoke and hadn't touched a drop of alcohol since she found
out she was pregnant. Her pregnancy had been problem-free until
three weeks earlier, when blood tests showed that her liver was a
little abnormal. Her OB had screened her for the most common forms
of hepatitis, but the tests were all fine. The doctor was going to
follow up at her next appointment. Could those liver abnormalities
be linked to this fever? About a week after the liver results, she
found a tick on her thigh, which she recognized as the type that
could carry Lyme disease. Could this illness be Lyme? She had been
on the lookout for the telltale rash but hadn't seen anything.

2. Investigation

Being a doctor, she was surrounded by doctors. "Sandy thinks you
have ehrlichiosis," her husband, also an internist, announced after
speaking with a friend who had gone through residency with the
couple. Ehrlichiosis, too, can be transmitted by a tick and can
cause both fever and transient liver abnormalities. A good
diagnosis, but the timing was wrong. The liver tests were abnormal
the week before she found the tick.

She called the OB-GYN again. He thought ehrlichiosis was pretty
unlikely. Even a healthy pregnant woman could get a viral illness,
he reasoned. Bed rest and Tylenol for the weekend, and they would
see how she was doing on Monday.

The patient hung up the phone completely unsatisfied. She couldn't
wait another day. What if this illness was hurting her baby? She
wanted a second opinion. She called a favorite professor of hers,
Vincent Andriole — an infectious-disease specialist. Right away he
wanted to look for the ehrlichia in her blood. One interesting thing
about these bacteria is that if you use the right stains, you can
sometimes see the organisms under the microscope. The tiny bugs look
like little clusters of round black dots trapped inside white blood
cells. "Morulae" are what these little clusters are called, Latin
for mulberries. He invited her to come immediately to the lab. She
sat miserably with her head in her arms as Andriole and her husband
scanned the blood smear under the microscope. No little clusters.
Too bad, Andriole said. That would have been a great diagnosis.

Normally, she might have just soldiered on, but there was her baby
to think about. The next day, she called another former teacher,
Michele Barry, who told her to come by the following morning. Barry
is a tiny tornado of a woman who exudes a restless energy that
leaves an impression of movement even when she's sitting still.

The patient looked tired but not severely ill, Barry noted as she
listened to her story. She didn't have a fever, and her blood was
getting enough oxygen. She had no rash. Her throat was a little red,
but her lymph nodes weren't swollen, and the rest of her exam was
normal. But she was pregnant, a time of reduced immunity. The body
is less able to fight off infections on its own. Also, whatever this
problem was, the treatment had to be one that would cure the mom
without injuring the fetus.

So what were the possibilities? Mononucleosis usually presents with
these very symptoms: fever, a reddened throat and abnormal liver-
function tests. The organism that causes mono, Epstein Barr, has
been implicated in a few reports of fetal abnormalities, though this
is a very rare complication. And in any case, there is no treatment
for mono. H.I.V., the virus that causes AIDS, was also possible. It
can cause this kind of fever and body aches. The patient's job as a
physician put her at higher risk for this disease, though she
couldn't recall any recent exposures. Still, if she had H.I.V. and
it wasn't diagnosed, the fetus could be infected at birth.
Toxoplasmosis was also a worry. This disease, which is found in
undercooked meat and is carried by cats, can cause terrible injury
to the unborn child. The woman did have a cat, and like most
pregnant women, she had been tested early on. That test showed that
she had never been exposed to the disease. Could she have it now?

3. Resolution

Barry would need to send blood for tests to look for each of these
infections. Finally, there was still the possibility of
ehrlichiosis. Morulae are seen in only one-third of ehrlichiosis
cases, and if you aren't able to see them under the microscope, it's
not easy to confirm the diagnosis. There are other tests, but they
won't be positive until the worst of the disease is over. Because of
this, diagnosis is usually based on the clinical picture, and
treatment, a strong antibiotic called doxycycline, tends to be
started before infection is confirmed. The patient's pregnancy made
this difficult, however. Physicians are loath to start any
medication during pregnancy, and doxycycline is particularly
dangerous for a fetus. Fortunately, Barry knew of a researcher who
was developing a diagnostic blood test for ehrlichiosis that could
quickly detect the DNA of the bacterium itself. The researcher
agreed to test the woman's blood that day.

Late that afternoon, Barry's pager chirped: the researcher had news.
He had found the bacteria's DNA in the patient's blood; she had
ehrlichiosis. Barry immediately called the patient with the news.
She had read of at least one case in which a pregnant patient had
been successfully treated with another antibiotic, rifampin, and put
the mother to be on it that day. "I started to feel better almost
immediately," she told me recently. When her liver was tested two
weeks later, the abnormalities had disappeared. Still, the sequence
of events troubled her. How could her liver have been abnormal
before she was even bitten by the tick? Could she have missed the
tick for all that time? That seemed unlikely. Was it possible that
the abnormal liver tests were just a coincidence? That seemed
unlikely, too. She favored another explanation, the two-tick theory —
that she'd been bitten by not one but two ticks and simply missed
the first. "If I hadn't been so persistent," the patient told me
recently, "I don't know how long it would have taken me to get a
definitive diagnosis. Maybe never." Barry agrees: "There was a rush
to get this diagnosis, and there should have been." Barry has seen
reports of cases in which ehrlichiosis is passed from mother to
fetus. Early intervention can prevent that, she said. And it seems
to have worked. Four months later, the patient gave birth to a
healthy baby girl.

If you have a solved case to share with Dr. Sanders, you can e-mail
her at LSanders@pol.net. She is unable to respond to all e-mail
messages.

*****
Letters to the Editor:
letters@nytimes.com

[blimeyitslymie]

Posted by: "Rose" toil_for_lyme@yahoo.com toil_for_lyme
Mon Oct 9, 2006 10:43 am (PST)
RoseNote: This article is from the Co-Cure archives (ME/CFS and
Fibromyalgia Information Exchange Forum). "ME" stands for Myalgic
Encephalomyelitis.
=========

http://listserv.nodak.edu/cgi-bin/wa...ind0610a&L=co-
cure&T=0&P=4190

From ME Essential, Issue 100. October 2006 pages 20 and 21.

Lyme Disease - let's dispel the myths

LD specialist Dr. Darrel Ho-Yen urges caution over the bug that can
be confused with ME.

The Internet has fuelled hysteria about Lyme disease. Lyme disease
(LD) was discovered in 1975, with the first human case due to
Borrelia burgdorferi being identified in 1983.

Whereas many may know that I wrote the first book on ME, Better
Recovery from Viral Illnesses, in 1985, and that this book is now in
its fourth edition, many may not know that my first scientific
publication on Lyme disease was in 1989, and that our laboratory in
Inverness provides a Lyme testing service for Scotland.

More importantly, I receive many emails, letters and telephone calls
on LD from all over the world. Such communications have one thing
in common: patients are worried about LD. Such anxieties and
concerns are based on what they have heard or read and what they are
being told by friends and relatives.

These myths are many and varied:

The Internet has the best information on Lyme disease

This seems a very reasonable statement as the Internet has access to
the most experts worldwide. The difficulty is separating the right
information from the wrong. There needs to be judgement on what is
being said. Unfortunately, looking for the right information can be
like looking for a needle in a haystack. It may be difficult to
find. In many cases, information on LD and ME is wrong.

Doctors are ignorant of LD

This appears to be an outrageous statement but has elements of truth
in it. LD is a recently identified illness and is described as "an
emerging infection." This means that many doctors have not studied
this infection at medical school and that more information is
emerging on this disease. This is not uncommon in medicine and
indeed is to be expected. It also has to be balanced by the fact
that not all areas of Britain have equal prevalence of LD. There
are many urban areas where LD is very uncommon whereas in rural
areas there is greater awareness and knowledge. Again, this is not
a judgement on the medical profession but simply a reflection of
reality. Those doctors in rural areas have to diagnose and manage
LD.

Most ME is Lyme Disease

LD is characterised by early and late disease. The clinical
syndromes of early disease are well recognised, such as the
characteristic rash (erythema migrans); whereas late disease has
characteristic clinical syndromes (for example, dermatological,
cardiac, rheumatoid), but also includes a fatigue state. Therefore,
it is only the late disease fatigue state that has common features
with ME. Overall, this may represent only 10% of all LD
infections. It is certainly not the majority of LD infections and
most ME sufferers do not have LD. In the Highlands of Scotland, we
have the greatest tick populations and it has been my routine in the
investigation of ME patients to have them tested for LD. In this
large series of patients who have had very significant exposure to
ticks, the number of ME patients who have LD as the cause of their
illness is around 5%.

Antibiotics can cure LD

This is a very attractive proposition. The truth of the matter is
that in LD, early disease is amenable to antibiotic treatment and is
curative.

Unfortunately, late disease does not have the same response to
antibiotics. In other countries, this has meant that prolonged
treatment with antibiotics (often a year or longer) has been
recommended. The very need for such prolonged treatment with
antibiotics suggests that the success rate is not good. Indeed, it
is difficult to separate the natural improvement that occurs with
chronic disease from the effects of antibiotic treatment.

Antibiotic treatment has limited success in late LD patients with
symptoms comparable to that of ME. Instead, such patients should be
managed, as is explained in my book, Better Recovery from Viral
Illnesses, fourth edition, www.dodonabooks.co.uk

All laboratories produce dependable results

All NHS laboratories in Britain have to be accredited by Clinical
Pathology Accreditation (UK) Ltd. If there is a diagnosis of LD
without such accreditation, the diagnosis is suspect. Many patients
are also seeking diagnosis by European or American Laboratories, and
many such laboratories do not have appropriate accreditation. It is
important to recognise that accreditation allows the user to have
confidence in the report. Unaccredited laboratories can produce
suspect results and may be influenced by the patient paying for the
test. Within the accredited laboratory, all of its procedures have
to be reproducible and subject to internal and external quality
assurance. This guarantees that quality of the product to the user.
Anyone receiving a diagnosis of LD should ensure that this is from
an accredited laboratory.

Misleading expert comment

Experts have said that LD is ten times more common than is reported.
This is absolutely true. Unfortunately, this statement is usually
applied to all LD infections: from asymptomatic, flu-like illness to
the well-defined clinical presentations. The number of patients
that fall into the group of late LD with a comparable illness such
as ME is small. LD accounts for 5% of ME patients in an area where
there is great tick exposure. In future, if there is better
diagnosis of LD, the amount of patients could double. However, the
important consideration is how these patients should be managed.

Summary

LD is a new, emerging infection. Much is being written and
discovered about this infection, and most of it is exciting and very
helpful. Unfortunately, the Internet and certain groups have
emphasised 10% of the information on LD rather than the 90%. It is
important that all ME patients have a balanced approach to
information on LD, especially as the management of late LD patients
is similar to that of ME patients in which there are no obvious
infectious disease causes. The answer is in making a balanced
judgement, taking responsibility for your illness and sticking to
guidelines. To blame others for not getting a diagnosis or
appropriate management may not be helpful. In the end, it is a
matter of what makes you better.

*Dr. Darrel Ho-Yen is head of microbiology at the Raigmore Hospital,
Inverness.
<snip to end>

****TOIL for Lyme****
T = Teach tolerance
0 = Overcome ignorance
I = Initiate insurance reform
L = Labor for Lyme literacy/advocacy

[blimeyitslymie]

Dr. Stricker to Debate at IDSA Symposium - Oct. 12, Toronto
Posted by: "Rose" toil_for_lyme@yahoo.com toil_for_lyme
Thu Oct 12, 2006 10:30 am (PST)
"This controversial topic will be debated at a symposium at this
year's IDSA meeting in Toronto on Thursday October 12th. "
========

Controversies in Lyme Disease Treatment and Diagnosis
to be Debated at Infectious Diseases Society of America (IDSA)
Symposium

International Lyme and Associated Diseases Society (ILADS) President
Featured

WHAT:
Medical experts agree about the importance of diagnosing Lyme
disease early enough to obtain the best treatment outcome and most
favorable prognosis, but some ask the question, Does Long-Term
Antibiotic Therapy Improve Persistent Symptoms Associated with Lyme
Disease? This controversial topic will be debated at a symposium at
this year's IDSA meeting in Toronto on Thursday October 12th.

WHERE:
Metro Toronto Convention Center, Room 801 A-B
Thursday, October 12, 2006, 2pm-4pm symposium, with debate beginning
at 3pm

WHY:
Clinical Practice guidelines issued this month by the Infectious
Diseases Society of America (IDSA) raise serious questions about
Lyme disease diagnosis and treatment options for patients and
practitioners. The International Lyme and Associated Disease Society
(ILADS), a non-profit, international multidisciplinary medical
society dedicated to the diagnosis and proper treatment of Lyme
disease, has its own set of guidelines that differ dramatically from
IDSA guidelines. More information at www.ilads.org.

WHO:
Dr. Raphael Stricker, ILADS president, will debate Dr. Paul
Auwaerter of Johns Hopkins University School of Medicine. Dr.
Stricker is Medical Director of Union Square Medical Associates, a
multispecialty medical practice in San Francisco where he treats
more than 900 Lyme disease patients.

CONTACT:
To set up an interview with Dr. Stricker, or for more information,
please contact: Sarah Habib,
MS&L Public Relations, Phone: 416- 847-1312, sarah.habib@ mslpr.ca


John F. Coughlan, President
Massachusetts Lyme Disease Awareness Assoc.
Cape Cod, MA
E-Mail: MassLyme@aol. com
Ph: (508) 564-7445

****TOIL for Lyme****
T = Teach tolerance
0 = Overcome ignorance
I = Initiate insurance reform
L = Labor for Lyme literacy/advocacy

[blimeyitslymie]

Posted by: "Rose" toil_for_lyme@yahoo.com toil_for_lyme
Sat Oct 14, 2006 10:10 am (PST)
"In looking at Lyme disease, abnormal QEEG patterns were found in 75
percent of active Lyme disease patients. With neurofeedback
treatment, 54 percent had continued cortical dysfunction."
=========

http://www.newswise.com/articles/view/524158/

NewsWise
October 9, 2006

Using Neurofeedback to Aid Medical Patients

Libraries
Medical News

Keywords
QUANTITATIVE ELECTROENCEPHALOGRAPHY, BIOFEEDBACK, NEUROFEEDBACK,
BRAIN WAVES,LYME DISEASE, SYSTEMATIC LUPUS, ERYTHEMATOSUS,
MIGRAINES, IRRITABLE BOWEL SYNDROME, FIBROMYALGIA AND CHRONIC
FATIGUE

Newswise — A new article reviews the literature of quantitative
electroencephalography (QEEG) that documents abnormal brain wave
patterns accompanying several medical conditions. The research
implies that neurofeedback training may partially or fully normalize
these brain wave patterns, and improve the physical and mental
functioning of people with these conditions. The article is in the
latest issue of Biofeedback.

The literature demonstrates that it is common to find disturbed
electrophysiological patterns associated with Lyme disease,
systematic lupus, erythematosus, migraines, irritable bowel
syndrome, and cardiopulmonary bypass surgery patients. Abnormal EEG
patterns are also commonly found in fibromyalgia and chronic fatigue
and in individuals with chemical sensitivities and those who have
been exposed to toxic substances or extensive radiation.

In looking at Lyme disease, abnormal QEEG patterns were found in 75
percent of active Lyme disease patients. With neurofeedback
treatment, 54 percent had continued cortical dysfunction. This is
one example of how some conditions in which viral agents persist
continue to need ongoing treatment in addition to neurofeedback.

The use of neurofeedback training can produce positive results for
those suffering from many diseases and disorders that are associated
with abnormal brain waves. The article can help to inform therapists
using neurofeedback by providing information for comparison with
their own assessments.

To read the entire study, click here:
http://www.allenpress.com/pdf/87-94_BIOF3403-art03.pdf

Biofeedback is a quarterly journal of the Association for Applied
Psychophysiology and Biofeedback (AAPB). For more information about
AAPB, visit http://www.aapb.org

****TOIL for Lyme****
T = Teach tolerance
0 = Overcome ignorance
I = Initiate insurance reform
L = Labor for Lyme literacy/advocacy

[blimeyitslymie]

Neurofeedback Training May Help Normalize Some Abnormal Brain Wave
Posted by: "Rose" toil_for_lyme@yahoo.com toil_for_lyme
Sat Oct 14, 2006 10:17 am (PST)
"According to Newswise, individuals with Lyme disease, systematic
lupus, erythematosus, migraines, irritable bowel syndrome, and
cardiopulmonary bypass surgery patients typically have disturbed
electroencephalography patterns."

========

http://www.allheadlinenews.com/articles/7005156955

All Headline News
October 12, 2006

Neurofeedback Training May Help Normalize Some Abnormal Brain Wave
Patterns

October 12, 2006 1:47 p.m. EST

Linda Young - All Headline News Staff Writer

Salt Lake City, Utah (AHN) - A new study reveals that neurofeedback
training may help normalize abnormal brain waves caused by some
medical conditions.

The study was published in the latest edition of Biofeedback a
journal published by the Association for Applied Psychophysiology
and Biofeedback.

According to Newswise, individuals with Lyme disease, systematic
lupus, erythematosus, migraines, irritable bowel syndrome, and
cardiopulmonary bypass surgery patients typically have disturbed
electroencephalography patterns.

Other conditions that may produce abnormal EEG patterns are
fibromyalgia, chronic fatigue and exposure to toxic substances or
large doses of radiation.

The study found that 75 percent of patients with Lyme disease had
abnormal EEG patterns. After neurofeedback treatment that declined
to 54 percent of those treated.

The report stated that these results could be used as baseline to
help therapists treat patients with abnormal brain wave patterns.

The study focused on children with migraines. The study was done by
D. Corydon Hammond, Ph.D., University of Utah School of Medicine.

****TOIL for Lyme****
T = Teach tolerance
0 = Overcome ignorance
I = Initiate insurance reform
L = Labor for Lyme literacy/advocacy

[blimeyitslymie]

From: Phyllis Mervine, President of CALDA
Subject: Fall Issue of the Lyme Times

Dear People,
The fall issue of the Lyme Times just went to the printer. It's a great
issue, 30 pages of interesting articles, including a description of a
highschooler' s project investigating a possible link between MS and
Lyme; a photo essay on alternate forms of borrelia by pathologist Alan
MacDonald, MD; a n article on "The Power and Peril of Paradigms" by Dave
Moyer; an article on the Marshall Protocol; one on pain; update on
federal bills and more. Please make sure your CALDA membership is up to
date (your expiration date is printed on the mailing label of your last
issue). Please consider ordering bulk issues (CALDA members get a
special discounted price) and using them for public education. We also
have back issues of the 2 children's issues (great for schools),
insurance issue, and patient's issue. Please contact Nancy Brown
<calda@dcacable. net> for bulk orders.

Sign up for a CALDA membership at www.lymedisease. org

To view archive issues go to www.lymetimes. org

The archives have only the pre-cover issues, our old newsprint style.

[blimeyitslymie]

http://www.newswire.ca/en/releases/a.../13/c8045.html

CNW Group
Canada
October 13, 2006

Attention News/Health Editors:

Warning - Health Canada warns consumers not to use unauthorized
intravenous health products due to potential health risks

OTTAWA, Oct. 13 /CNW Telbec/ - Health Canada is warning
consumers and health practitioners not to use the unauthorized
intravenous products Bismacine (also known as Chromacine),
Dioxychlor (also known as DC-3) and Sulfoxime because they may pose
a serious risk to health.

These products have been promoted as an intravenous protocol to
treat Lyme disease, a tick-bourne illness. Additionally, Dioxychlor
and Sulfoxime injections have been promoted for the treatment of
other health conditions. Together, Sulfoxime and Dioxychlor are
promoted as anti-microbial agents.

Bismacine is not an authorized health product in Canada;
however, it has been available for sale from compounding pharmacies
in the United States. Bismacine contains high amounts of bismuth, a
heavy metal that is authorized for use in some oral medications to
treat Helicobacter pylori, a bacterium that can cause stomach
ulcers. However, using bismuth through injection may result in
cardiovascular collapse, kidney failure or death.

There is evidence that Dioxychlor and Sulfoxime, although not
authorized by Health Canada, have been purchased by Canadians, in
Ontario, Quebec and Nova Scotia, from a U.S. Internet pharmacy.

Bismacine, Dioxychlor or Sulfoxime injections are not recognized
naturopathic practices in Canada and they are not used by licensed
naturopathic doctors in Canada for the treatment of Lyme disease or
any other condition.

All three products are manufactured by American Biologics of
Chula Vista, California. The same manufacturer markets a device
called the Bradford High Resolution Microscope as a tool to diagnose
Lyme disease. This device has not been reviewed or approved by
Health Canada.

Lyme disease occurs mainly during the summer. It is treated with
antibiotics, either orally or intravenously, depending on the
severity of the disease. Visit the It's Your Health fact
sheet
(http://www.hc-sc.gc.ca/iyh-vsv/disea...es/lyme_e.html) for more information on Lyme
disease.

To date, no adverse reactions suspected to be associated with
these products have been reported to Health Canada. However, there
has been one death and several reports of injury related to
treatment with Bismacine in the United States.

Health Canada is advising consumers and health practitioners not
to use Bismacine, Dioxychlor or Sulfoxime for the treatment of any
medical condition, including Lyme disease. Individuals who believe
they have suffered side-effects from using these products are
advised to seek medical attention immediately. Health Canada is also
advising consumers and health practitioners not to use the Bradford
High Resolution Microscope to diagnose any medical condition.

Consumers requiring more information about this advisory can
contact the Health Canada public inquiries line at (613) 957-2991,
or toll free at 1-866-225-0709.

To report a suspected adverse reaction to these or any other
health products, please contact the Canadian Adverse Drug Reaction
Monitoring Program (CADRMP) of Health Canada by one of the following
methods:

Telephone: 1-866-234-2345
Facsimile: 1-866-678-6789

CADRMP
Marketed Health Products Directorate
Tunney's Pasture, AL 0701C
email: cadrmp@hc-sc.gc.ca

The CADRMP adverse reaction reporting form, including a version
that can be completed and submitted online, is located on the
MedEffect portal (www.medeffect.gc.ca) of the Health Canada Web site.

Egalement disponible en fran*ais

For further information: Media Inquiries: Health Canada, (613) 957-
2983;
Public Inquiries: (613) 957-2991, 1-866 225-0709

[blimeyitslymie]

http://www.lymediseaseassociation.or.../20061018.html

Lyme Disease Association Website
October 18, 2006

Media Advisory:
October 18, 2006

Contact: Vicky Jaffe, 617-937-2578,
Vicky.jaffe@mslpr.com

Latest Lyme Disease Research to be Presented Oct. 20-22 in
Philadelphia
Featured Presentations include Lyme Disease Link to Alzheimer's

The recent frost unofficially ends the high-risk season for Lyme
disease infection, but with warmer, wetter weather over the past
year, and ticks continuing to be active over the winter, experts
predict 2006 may surpass 2005 for the number of reported Lyme
disease cases. In the United States, 23,305 Lyme disease cases were
reported by the Centers for Disease Control in 2005, but only 10
percent of cases meeting the CDC criteria are actually reported.
Therefore, about 233,050 U.S. cases that met the CDC criteria
occurred in 2005. Other physician-diagnosed cases that do not meet
the narrow CDC criteria are not counted anywhere. The continued toll
of Lyme disease brings together hundreds of physicians, researchers,
health care providers, advocates and patients looking for the latest
information about the most common tick-borne disease in the world
today.

The 7th Annual Lyme Disease Association (LDA) Lyme & Other Tick-
Borne Diseases Conference will be held on Friday, Oct. 20 at the
Crowne Plaza Hotel, Center City, Philadelphia, jointly sponsored by
the Columbia University College of Physicians and Surgeons which
offers physicians continuing medical education credits for the one
day session.

Highlights of presentations include:
• Pathologist Alan B. MacDonald, MD, will present his findings at
3pm on Friday, Oct. 20 that Borrelia burgdorferi (the bacteria that
causes Lyme disease, typically found in a spiral form) can take
different shapes when it invades mammals, including cystic forms and
granular forms that may be found inside of neurons in Alzheimer's
disease in the Hippocampus. Three abstracts of Dr. MacDonald's were
accepted at this year's International Meeting of the Alzheimer's
Disease Association in Madrid, Spain and have been published
in "Alzheimer's and Dementia," a publication of the Alzheimer's
Society.

• On Friday at 8:15 am, keynoter David Ecker, Ph.D., Chief
Scientific Officer at the Ibis Division of Isis Pharmaceuticals in
Carlsbad, CA, will discuss universal biosensor detection of emerging
infections, which has applications for Lyme, as well as other
infectious diseases.

• On Friday at 10:40am, Dr. Jeffrey D. Rothstein of Johns Hopkins
University will discuss the ability of antibiotics to stimulate
Glutamate Transporter Expression and delay the loss of neurons and
muscle strength in animal models with ALS.

The International Lyme and Associated Diseases Society (ILADS)
Scientific Session on tick-bore diseases will follow over the
weekend.

[blimeyitslymie]

"A few of the participants have been diagnosed with 3rd stage Lyme
disease and failed to improve with pharmaceutical treatment,
including antibiotics."

http://www.npicenter.com/anm/templates/newsATemp.aspx?
articleid=16751&zoneid=18

NPI Center
October 9, 2006

Allimax Nutraceuticals US starts clinical trial for treating Lyme
disease
2006-10-09 - Allimax Nutraceuticals US

________________________________________

Allimax Nutraceuticals US, in conjunction with the Health Healing
and Hope Foundation, have started their Lyme disease double blind
clinical study being conducted in Texas by Dr.'s Joan Vandergriff
ND, Hamid Moayad DO, William Keller Ph.D., Hugo Rodier M.D. The
study is being sponsored by Natures Sunshine Products and Allimax
International L.T.D. The purpose of the study is to show eradication
of the blood born Borrelia Spirochete causing Lyme disease.

Lyme disease can affect every organ in the human system and can
decimate health. A few of the participants have been diagnosed with
3rd stage Lyme disease and failed to improve with pharmaceutical
treatment, including antibiotics. Some pilot investigation was done
using a rotation of drugs combined with natural therapies. Despite
improvement, Lyme protocol dictates a rotation of allopathic/natural
therapy. The goal is to show alternative therapies can make a
difference in 3rd stage Lyme disease using a uniform natural therapy
regimen.

The company has chosen patients who failed to respond or improve
from conventional therapy. In the study the natural treatment
Allimed® group will be compared to at least the same matching number
of other patients of approximately the same age, sex, blood type and
degree of illness who continue to receive conventional therapy
without natural therapies (the control group).

James R. Walton, President
Allimax Nutraceuticals US
312-421-6132 Office
312-421-6133 Fax
www.allimax.us
www.allimed.us

[blimeyitslymie]

http://biz.yahoo.com/prnews/061002/nym075a.html?.v=1

Yahoo Finance
October 2, 2006

Press Release Source: Novozymes

Novozymes Expands Product Portfolio with Efficacious Biological
Insecticide for Deer Ticks, Lyme Disease

Monday October 2, 10:00 am ET

Company completes acquisition of Connecticut-based Earth
Biosciences, Inc.

SALEM, Va., Oct. 2 /PRNewswire/ -- Novozymes today announced it has
acquired a natural insecticide which may deter Lyme disease by
controlling the deer tick, one of the carriers of the disease.
Acquiring the insecticide came as part of the recently completed
acquisition of Earth Biosciences, Inc. (EBS), which closed September
30, 2006. Novozymes will incorporate EBS into its ROOTS ® Plant Care
Group.

Lyme disease is caused by a spirochete pathogen and is spread to
humans by deer ticks. The infectious disease, which can cause
arthritis, neurological and heart problems, is more prevalent
throughout the northeastern and midwestern states of the U.S. and in
Europe.

In the transaction, Novozymes will add two new alternative pesticide
technologies to its portfolio. These include the insecticide
Metarhizium anisopliae and the fungicide Bacillus subtilis, both
naturally occurring microorganisms. The Metarhizium portfolio will
include a full registration package with approved U.S. Environmental
Protection Agency and European registrations. This new insecticide
product is currently approved for residential outdoor control of
ticks and the control of important ornamental pests such as black
vine weevils, a very serious nursery pest in the US, Holland, Italy,
Germany, France, UK and Spain.

The acquisition combines ROOTS ® Plant Care Group technical and
sales support, development tools and biostimulant and micronutrient
product portfolio for growth enhancement in the turf and nursery
industries, with EBS' proven and trusted technology for insect
control.

"With the acquisition of ROOTS ® Plant Care Group three years ago
and now the acquisition of EBS, Novozymes continues to strengthen
its position as the world leader in the research, development and
manufacture of biotechnology products and natural pest
technologies," stated John Sedivy, Novozymes director of business
development.

"The acquisition of EBS simultaneously meets Novozymes' objectives
for strategic growth: we are entering an attractive new market
segment as well as expanding our positions into important geographic
markets that we already serve."

According to Novozymes Biologicals president Ted Melnik, the company
will make additional investments to bring these new technologies to
market and begin production. "The investment of additional funds in
the technology acquisition should signal our full-fledged commitment
to the biological pesticide market and reaffirm our position as a
biotechnology leader, and the right company to make this happen," he
said.

With a technology platform of applied microbiology, Novozymes
Biologicals produces live microbial products for a variety of
applications, including cleaning and odor control for institutional
and household products, industrial and municipal waste treatment
products, and new technologies for animal health and plant care.
Novozymes' microorganisms business and all related activities are
the responsibility of Novozymes Biologicals, Inc., a wholly owned
subsidiary of Novozymes A/S.

Novozymes A/S is the biotech-based world leader in enzymes and
microorganisms. Using nature's own technologies, we continuously
expand the frontiers of biological solutions to improve industrial
performance everywhere. Visit www.novozymes.com.

________________________________________

Source: Novozymes